CD34-selected hematopoietic stem cell transplants conditioned with myeloablative regimens and anti-thymocyte globulin for advanced myelodysplastic syndrome: limited graft-versus-host disease without increased relapse. Biol Blood Marrow Transplant. 2015.
Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: Strain diversity and outcomes associated with NAP-1 /027. Biol Blood Marrow Transplant. 2014.
Drugs as a Frequent Cause of Acute Rash in Patients After CD34-selected Peripheral Blood Stem Cell Transplantation. Biol Blood Marrow Transplant. 2019..
The Effect of Aging and Pre-Donation Comorbidities on the Related PBSC Donor Experience: A Report from the Related Donor Safety Study (RDSafe). Biol Blood Marrow Transplant. 2018.
Ex Vivo T Cell-Depleted Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Myeloid Leukemia in First and Second Remission: Long-Term Disease-Free Survival with a Significantly Reduced Risk of Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2019.
Histopathologic Features of Cutaneous Acute Graft-Versus-Host Disease in T-Cell-Depleted Peripheral Blood Stem Cell Transplant Recipients. Am J Dermatopathol. 2015;37(7):523-529..
Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation. Blood. 2014.
Pre-transplant cognitive dysfunction in advanced-age hematologic cancers: predictors and associated outcomes. Biol Blood Marrow Transplant. 2020..